Correct Answer: A. Etomidate
Etomidate is the only IV anesthetic among the options that does NOT cause myocardial depression. This is its defining pharmacological advantage in hemodynamically unstable patients. Etomidate maintains cardiovascular stability through preservation of sympathetic tone and baroreceptor reflexes, with minimal effects on myocardial contractility and systemic vascular resistance. Its mechanism involves GABA-A receptor agonism without the direct myocardial depressant effects seen with other agents. In Indian clinical practice, etomidate is the preferred induction agent for critically ill patients, septic shock, hemorrhagic shock, and those with compromised cardiac function. The drug maintains airway reflexes reasonably well and provides rapid onset (30–40 seconds) with short duration (5–10 minutes). However, a critical limitation is its single-dose adrenocortical suppression (inhibits 11β-hydroxylase), which is clinically significant in prolonged infusions or repeated dosing in ICU settings—a point often tested alongside its cardiovascular benefits. The cardiovascular stability makes it ideal for induction in emergency departments and trauma settings where hemodynamic collapse is a risk.
Why the other options are wrong
B. Ketamine — While ketamine causes sympathomimetic effects (tachycardia, hypertension) due to catecholamine release and CNS stimulation, it DOES cause direct myocardial depression at the cellular level. This depression is masked clinically by sympathetic activation, but in catecholamine-depleted states (chronic critical illness, sepsis) or when combined with sympatholytics, myocardial depression becomes apparent. Ketamine is NOT the answer because the question asks for an agent that does NOT cause myocardial depression—the mechanism matters, not just the net clinical effect. C. Propofol — Propofol causes significant myocardial depression through multiple mechanisms: direct negative inotropic effect, peripheral vasodilation, and reduced sympathetic outflow. It causes dose-dependent decreases in systolic and diastolic blood pressure, cardiac output, and systemic vascular resistance. In Indian ICUs, propofol infusion syndrome (PRIS) is a recognized complication with prolonged infusions, characterized by refractory bradycardia, metabolic acidosis, and cardiovascular collapse. Propofol is contraindicated in hemodynamically unstable patients and is NOT suitable for induction in shock states. D. Thiopentone — Thiopentone is a barbiturate that causes profound myocardial depression through direct negative inotropic effects and central sympathetic depression. It causes significant decreases in blood pressure, cardiac output, and systemic vascular resistance, with effects proportional to dose and speed of injection. Although thiopentone was historically used for induction, it is now largely abandoned in India due to its cardiovascular risks, availability of safer alternatives (etomidate, ketamine), and potential for severe complications in compromised patients. It is contraindicated in hypovolemia and shock.
High-Yield Facts
- Etomidate is the only IV anesthetic that does NOT cause myocardial depression—it maintains cardiac output and SVR through preserved sympathetic tone.
- Etomidate's onset is 30–40 seconds with duration of 5–10 minutes; metabolism is by hepatic ester hydrolysis and plasma esterases.
- Single-dose adrenocortical suppression (inhibition of 11β-hydroxylase) occurs with etomidate; clinically significant in prolonged infusions or repeated dosing in ICU.
- Propofol causes dose-dependent myocardial depression, peripheral vasodilation, and propofol infusion syndrome (PRIS) with prolonged infusions.
- Ketamine causes direct myocardial depression masked by sympathomimetic effects; depression unmasked in catecholamine-depleted states.
- Thiopentone causes profound myocardial depression and is now obsolete in Indian anesthesia practice due to cardiovascular risks.
Mnemonics
IV Anesthetics & Myocardial Depression (KEPT) Ketamine (direct depression masked by sympathomimetic effects) | Etomidate (NO depression—sympathetic preservation) | Propofol (profound depression) | Thiopentone (tremendous depression). Use: Remember E is the exception—the only one that doesn't depress the heart. Etomidate's Advantage: 'STABLE' Sympathetic tone preserved | Timing 30–40 sec | Adrenocortical suppression (caveat) | Blood pressure maintained | Low myocardial depression | Excellent for shock. Use: When choosing induction in hemodynamically unstable patients.
NBE Trap
NBE pairs etomidate with adrenocortical suppression to distract from its cardiovascular advantage—students may incorrectly eliminate it thinking the hormonal side effect makes it unsuitable, when in fact the question specifically asks about myocardial depression, not endocrine effects. The trap is conflating different adverse effects.
Clinical Pearl
In Indian emergency departments and trauma centers, etomidate is the gold standard for rapid sequence intubation in hemorrhagic shock and septic patients because it alone preserves blood pressure during induction—a life-saving distinction when every mmHg of perfusion pressure matters. However, always remember to avoid prolonged infusions due to adrenocortical suppression risk in ICU settings.
_Reference: KD Tripathi Pharmacology Ch. 12 (IV Anesthetics); Harrison Ch. 451 (Anesthesia); Guyton Physiology Ch. 60 (Anesthesia)_